Sorrento Therapeutics Inc
Change company Symbol lookup
Select an option...
SRNE Sorrento Therapeutics Inc
ALLT Allot Ltd
AMZN Amazon.com Inc
DAC Danaos Corp
EMF Templeton Emerging Markets Fund Inc.
CVS CVS Health Corp
DIS Walt Disney Co
MPC Marathon Petroleum Corp
NOK Nokia Oyj
NVAX Novavax Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Sorrento Therapeutics, Inc. is a clinical-stage and commercial biopharma company. The Company operates through two segments: Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next generation of cancer therapeutics. These modalities include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy (DAR-T), antibody-drug conjugates (ADC), as well as bispecific antibody approaches. Additionally, Sorrento Therapeutics segment also includes Sofusa, a drug delivery technology that delivers biologics directly into the lymphatic system to potentially achieve improved efficacy and fewer adverse effects than standard parenteral immunotherapy. The Scilex segment is organized around its non-opioid pain management operations.

Price
Delayed
$13.62
Day's Change
0.775 (6.04%)
Bid
--
Ask
--
B/A Size
--
Day's High
14.55
Day's Low
12.30
Volume
(Heavy Day)

Today's volume of 102,900,810 shares is on pace to be much greater than SRNE's 10-day average volume of 40,924,301 shares.

102,900,810
  • Prev Close
    12.84
  • Today's Open
    14.31
  • Day's Range
    12.30-14.55
  • Avg Vol (10-day)
    40.9M
  • Last (time)
    12:53p ET 08/05/20
  • Last (size)
    100
  • 52-Wk Range
    1.39 - 14.55
    LowHigh
  • (10/11/19 - 08/05/20)
    6.43%
  • 156.6%
  • Market Cap
    2.8B
  • Shares Outstanding
    209.7M
  • -1.72
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 3.1
  • 16.17
  • (% of float 07/15/20)
    34.50

Latest News

August 05, 2020
1:01 pm ET
MarketWatch
9:39 am ET
PR Newswire
August 04, 2020
9:31 am ET
PR Newswire
August 03, 2020
9:43 am ET
PR Newswire
9:37 am ET
PR Newswire
July 29, 2020
9:31 am ET
PR Newswire
9:00 am ET
PR Newswire
July 27, 2020
1:14 pm ET
Newsfile
11:02 am ET
Newsfile
10:53 am ET
Accesswire
10:17 am ET
Newsfile
6:21 am ET
Accesswire
July 24, 2020
2:29 pm ET
Newsfile
11:10 am ET
Accesswire
10:21 am ET
Newsfile
9:00 am ET
PR Newswire
July 23, 2020
5:51 pm ET
Accesswire
1:30 pm ET
Accesswire
12:00 pm ET
Globe Newswire
11:44 am ET
Accesswire
10:17 am ET
Newsfile
10:08 am ET
PR Newswire
July 22, 2020
8:13 pm ET
Accesswire
7:00 pm ET
BusinessWire
6:13 pm ET
Newsfile
2:29 pm ET
Newsfile
1:02 pm ET
Newsfile
11:10 am ET
Accesswire
10:11 am ET
Newsfile
July 21, 2020
11:15 am ET
Accesswire
10:08 am ET
Newsfile
6:22 am ET
Accesswire
July 20, 2020
11:50 am ET
Accesswire
10:35 am ET
PR Newswire
10:05 am ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.